102 related articles for article (PubMed ID: 2739903)
21. A radioimmunoassay for the tripeptide Gly-Trp-Met, a major metabolite of endogenous cholecystokinin in brain.
Rose C; Vargas F; Bourgeat P; Schwartz JC
Neuropeptides; 1996 Jun; 30(3):231-5. PubMed ID: 8819147
[TBL] [Abstract][Full Text] [Related]
22. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Law JK; Marabout B; Luthra PM; Moore AN; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2000 Feb; 43(4):664-74. PubMed ID: 10691692
[TBL] [Abstract][Full Text] [Related]
24. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
25. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
[TBL] [Abstract][Full Text] [Related]
26. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra.
Benoliel JJ; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1992 Mar; 58(3):916-22. PubMed ID: 1310726
[TBL] [Abstract][Full Text] [Related]
27. Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.
Griesbacher T; Leighton GE; Hill RG; Hughes J
Br J Pharmacol; 1989 Jan; 96(1):236-42. PubMed ID: 2647203
[TBL] [Abstract][Full Text] [Related]
28. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on proline-containing neuropeptides.
Mentlein R; Struckhoff G
J Neurochem; 1989 Apr; 52(4):1284-93. PubMed ID: 2564425
[TBL] [Abstract][Full Text] [Related]
29. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
Song B; Marvizón JC
J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cholecystokinin metabolism by membrane preparations from the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
Medeiros Mdos S; Turner AJ
Neurochem Int; 1994 Apr; 24(4):369-77. PubMed ID: 7914787
[TBL] [Abstract][Full Text] [Related]
31. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.
Migaud M; Durieux C; Viereck J; Soroca-Lucas E; Fournié-Zaluski MC; Roques BP
Peptides; 1996; 17(4):601-7. PubMed ID: 8804068
[TBL] [Abstract][Full Text] [Related]
32. Is the seryl residue essential for catalytic activity of rat liver arginase?
Muszyńska G; Wojtczak M
Biochem Biophys Res Commun; 1982 Aug; 107(4):1167-72. PubMed ID: 6814435
[No Abstract] [Full Text] [Related]
33. A cytotoxic serine proteinase isolated from mouse submandibular gland.
Shimamura T; Nagumo N; Ikigai H; Murakami K; Okubo S; Toda M; Ohnishi R; Tomita M
Immunol Lett; 1989 Aug; 22(2):155-9. PubMed ID: 2789187
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra.
Diez-Guerra FJ; Sirinathsinghji DJ; Emson PC
Neuroscience; 1988 Nov; 27(2):527-36. PubMed ID: 2905788
[TBL] [Abstract][Full Text] [Related]
35. Specificity of neurotensin metabolism by regional rat brain slices.
Davis TP; Gillespie TJ; Konings PN
J Neurochem; 1992 Feb; 58(2):608-17. PubMed ID: 1729405
[TBL] [Abstract][Full Text] [Related]
36. Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro.
Koulischer D; Moroder L; Deschodt-Lanckman M
Regul Pept; 1982 Aug; 4(3):127-39. PubMed ID: 6291099
[TBL] [Abstract][Full Text] [Related]
37. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
Deschodt-Lanckman M; Strosberg AD
FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
[TBL] [Abstract][Full Text] [Related]
38. Is substance P released from slices of the rat spinal cord inactivated by peptidase(s) distinct from both 'enkephalinase' and 'angiotensin-converting enzyme'?
Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
Neurosci Lett; 1991 Feb; 123(2):221-5. PubMed ID: 1709269
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
Browne P; O'Cuinn G
Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
[TBL] [Abstract][Full Text] [Related]
40. Peptidases involved in the catabolism of neurotensin: inhibitor studies using superfused rat hypothalamic slices.
McDermott JR; Virmani MA; Turner JD; Kidd AM
Peptides; 1986; 7(2):225-30. PubMed ID: 3526299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
